158 related articles for article (PubMed ID: 24111798)
21. Intercritical photophobia in the migraineous patient. Proposal for diagnostic criteria.
Ly-Yang F; Gómez-Calleja V; Pérez-García P; González-Gómez N; Porta-Etessam J; Santos-Bueso E
Neurologia (Engl Ed); 2021 Feb; ():. PubMed ID: 33622562
[TBL] [Abstract][Full Text] [Related]
22. Photophobia in primary headaches, in essential blepharospasm and in major depression.
Anagnostou E; Vikelis M; Tzavellas E; Ghika A; Kouzi I; Evdokimidis I; Kararizou E
Int J Neurosci; 2017 Aug; 127(8):673-679. PubMed ID: 27580344
[TBL] [Abstract][Full Text] [Related]
23. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
Navratilova E; Rau J; Oyarzo J; Tien J; Mackenzie K; Stratton J; Remeniuk B; Schwedt T; Anderson T; Dodick D; Porreca F
Cephalalgia; 2019 Dec; 39(14):1762-1775. PubMed ID: 31550910
[TBL] [Abstract][Full Text] [Related]
24. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP.
Recober A; Kaiser EA; Kuburas A; Russo AF
Neuropharmacology; 2010 Jan; 58(1):156-65. PubMed ID: 19607849
[TBL] [Abstract][Full Text] [Related]
25. Effects of endurance exercise on serum concentration of calcitonin gene-related peptide (CGRP): a potential link between exercise intensity and headache.
Tarperi C; Sanchis-Gomar F; Montagnana M; Danese E; Salvagno GL; Gelati M; Skroce K; Schena F; Lippi G
Clin Chem Lab Med; 2020 Sep; 58(10):1707-1712. PubMed ID: 32286239
[TBL] [Abstract][Full Text] [Related]
26. A quantitative assessment of photophobia in migraine and tension headache.
Drummond PD
Headache; 1986 Oct; 26(9):465-9. PubMed ID: 3781834
[No Abstract] [Full Text] [Related]
27. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
[TBL] [Abstract][Full Text] [Related]
28. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
[TBL] [Abstract][Full Text] [Related]
29. Index of suspicion.
Fanella S; Embree J; Arora B; Goel S; Probst FJ; Patel A; Beaudet AL
Pediatr Rev; 2008 Aug; 29(8):281-7. PubMed ID: 18676580
[No Abstract] [Full Text] [Related]
30. Cluster headache with short-lived visual symptoms.
Fattah QA; Cutrer FM
Cephalalgia; 2006 Apr; 26(4):492-3. PubMed ID: 16556254
[No Abstract] [Full Text] [Related]
31. Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
Ament M; Day K; Stauffer VL; Skljarevski V; Rettiganti M; Pearlman E; Aurora SK
J Headache Pain; 2021 Feb; 22(1):6. PubMed ID: 33549036
[TBL] [Abstract][Full Text] [Related]
32. A patient with long-lasting attacks of bilateral 'blepharospasm', photophobia, lacrimation and rhinorrhoea.
van Vliet JA; Haan J; Ferrari MD
Cephalalgia; 2004 Feb; 24(2):143-6. PubMed ID: 14728711
[No Abstract] [Full Text] [Related]
33. Current understanding of trigeminal ganglion structure and function in headache.
Messlinger K; Russo AF
Cephalalgia; 2019 Nov; 39(13):1661-1674. PubMed ID: 29989427
[TBL] [Abstract][Full Text] [Related]
34. Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately.
Mulleners WM; Aurora SK; Chronicle EP; Stewart R; Gopal S; Koehler PJ
Headache; 2001 Jan; 41(1):31-9. PubMed ID: 11168601
[TBL] [Abstract][Full Text] [Related]
35. Hypothalamic regulation of headache and migraine.
May A; Burstein R
Cephalalgia; 2019 Nov; 39(13):1710-1719. PubMed ID: 31466456
[TBL] [Abstract][Full Text] [Related]
36. Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury.
Bree D; Mackenzie K; Stratton J; Levy D
Cephalalgia; 2020 Jun; 40(7):748-760. PubMed ID: 32077327
[TBL] [Abstract][Full Text] [Related]
37. Clinical pearls: can they be of more than anecdotal value?
Geweke LO
Headache; 2005 Jun; 45(6):763. PubMed ID: 15953314
[No Abstract] [Full Text] [Related]
38. Ascertainment of photophobia and phonophobia during migraine: preferred close-ended questions.
Evans RW
Headache; 2004; 44(10):1057-8. PubMed ID: 15546277
[No Abstract] [Full Text] [Related]
39. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
[TBL] [Abstract][Full Text] [Related]
40. The role of vasoactive neuropeptides in the genesis of venous pelvic pain: A review.
Gavrilov SG; Vassilieva GY; Vasilev IM; Grishenkova AS
Phlebology; 2020 Feb; 35(1):4-9. PubMed ID: 31185797
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
